Rethinking long-term allergy treatments: Experimental vaccine protects against anaphylaxis in mice

Researchers led by the Institut Pasteur, Université Paris, have developed a vaccine that elicits anti-Immunoglobulin E ...

New antibody boosts immune response against blood cancers and solid cancers

In a recent preclinical study, researchers from The University of Texas MD Anderson Cancer Center developed an antibody ...
Healio

Rosnilimab achieves T-cell depletion, ‘clinical proof of concept’ in rheumatoid arthritis

CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive ...